Oxford BioDynamics (LMQ) Income Statement
Oxford BioDynamics Income Statement
Last quarter (Q2 2026), Oxford BioDynamics's total revenue was $687.00K, an increase of 110.09% from the same quarter last year. In Q2, Oxford BioDynamics's net income was $-4.46M. See Oxford BioDynamics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| $ 1.09M | $ 636.00K | $ 510.00K | $ 154.00K | $ 341.00K | |
| $ -6.15M | $ 289.00K | $ 266.00K | $ 116.00K | $ -557.00K | |
| $ 4.51M | $ 13.18M | $ 10.43M | $ 8.72M | $ 6.96M | |
| Depreciation and Amortization | $ 1.20M | $ 1.47M | $ 1.36M | $ 1.21M | $ 1.09M |
| $ -9.80M | $ -10.27M | $ -9.84M | $ -6.16M | $ -6.43M | |
| $ -10.66M | $ -12.89M | $ -11.03M | $ -8.60M | $ -7.51M | |
| $ -759.00K | $ 938.00K | $ -416.00K | $ 1.03M | $ -117.00K | |
| $ -11.42M | $ -11.96M | $ -11.41M | $ -7.57M | $ -7.63M | |
| $ -11.15M | $ -11.57M | $ -10.83M | $ -6.71M | $ -6.68M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.05 | $ -0.07 | $ -0.07 | $ -0.07 |
| Diluted EPS | $ -0.01 | $ -0.05 | $ -0.07 | $ -0.07 | $ -0.07 |
| Weighted Average Shares Outstanding | 1.39B | 255.73M | 147.48M | 99.70M | 92.56M |
| Weighted Average Shares Outstanding (Diluted) | 1.39B | 255.73M | 147.48M | 99.70M | 92.56M |
Currency in GBP